文献速递间质性肺疾病肺结节与肺癌

肺癌合并间质性肺疾病的回顾性分析及横断面问卷调查研究

[Retrospective analysis and a cross-sectional questionnaire survey of lung cancer concomitant with interstitial lung disease].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2022-01-01

结果显示LC-ILD以老年男性多见,腺癌最常见,手术组分期早且预后更好(P<0.001);医师认知存在分歧,多数认为应视ILD严重程度决定是否手术。

要点

  • LC-ILD患者以老年男性为主,腺癌是最常见病理类型。
  • 早期肺癌手术切除后预后相对更好,但需结合ILD病情程度考量手术。
  • 医师对晚期LC-ILD的非手术治疗及ILD治疗措施存在较大分歧。

核心结论

  • LC-ILD患者以老年、男性多见,腺癌是常见病理类型。
  • 建议结合ILD病情程度考量是否外科手术,早期肺癌患者手术切除后预后相对好。

主要发现

  • 70例LC-ILD患者中男性52例,平均年龄(64.3±7.63)岁(范围49~84岁),≥60岁共51例。
  • 腺癌是最常见病理类型,绝大部分患者肺癌和ILD同时诊断,化疗是最常用内科治疗措施。
  • EGFR或ALK基因突变阳性11例(15.7%);45例(64.3%)死亡,其中33例死于肺癌进展。
  • 外科手术组17例(24.3%)与非手术组53例(75.7%)在年龄、病理类型、驱动基因突变方面无差异,但手术组肺癌分期早、预后更好(P<0.001)。
  • 问卷反馈中,老年(785份/77.4%)、男性(720份/71%)被认为是好发人群;腺癌(390份/38.5%)、腺癌或鳞癌(182份/17.9%)、鳞癌(151份/14.9%)是常见病理类型。

关键数值与推荐

  • EGFR或ALK突变阳性率为15.7%(11/70)。
  • 死亡患者中64.3%(45/70)死亡,其中33例死于肺癌进展。
  • 外科手术组与非手术组预后差异有统计学意义(P<0.001)。

临床怎么用

  • 对LC-ILD患者应评估ILD严重程度以决定是否外科手术,早期肺癌手术切除可能改善预后。
  • LC-ILD常见于老年男性,腺癌多见,临床需关注肺癌与ILD的同时诊断。
  • 医师对晚期LC-ILD的非手术治疗及ILD治疗存在分歧,需进一步规范化。

局限性

  • 回顾性单中心研究,样本量70例,可能存在选择偏倚。
  • 问卷为横断面调查,仅反映医师认知现况,不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To describe the clinical characteristics and prognosis of lung cancer concomitant with interstitial lung disease (LC-ILD), and to understand the current status of knowledge of LC-ILD by physicians in the departments related to the treatment of the disease. Methods: We conducted a retrospective analysis of in-hospitalized pathology identified lung cancer (LC) patients who were admitted to our hospital between January 2014 and December 2018. After reviewing their chest CT imagings and pathological reports, 70 patients who were concomitant with interstitial lung disease (ILD) were enrolled in our study. On the other hand, a cross-sectional survey using an online questionnaire was conducted in LC-ILD management doctors who came from 29 provincial hospitals. The perceptions of demographic features, LC characteristics and management, ILD characteristics and management, and the prognosis of LC-ILD were investigated. Results: Among the 70 enrolled LC-ILD cases, there were 52 males, and the mean age was (64.3±7.63) years (ranged from 49 years to 84 years). There were 51 patients who were older than 59 years. The most common pathological pattern of LC was adenocarcinoma. Most of them were diagnosed with LC and ILD simultaneously, and they were usually treated with chemotherapy while unresectable. There were 11 patients (15.7%) with positive EGFR or ALK mutation. Forty-five patients (64.3%) died during the follow-up, and 33 were died from LC progression. There were no significant differences between the surgical group and non-surgical group on age, pathological patterns, EGFR or ALK mutation. However, LC-ILD patients in the surgical group were diagnosed with earlier TNM classification and with better prognosis. A total of 1 014 doctors answered the questionnaire completely. In the feedback, patients aged 60 years and older (785 doctors/77.4%), and male patients (720 doctors/71%) were the predominant LC-ILD patients. Adenocarcinoma (390 doctors/38.5%), adenocarcinoma or squamous-cell cancer (SCC) (182 doctors/17.9%), and SCC (151 doctors/14.9%) were considered as the common pathological patterns of LC-ILD patients. In most doctors' feedback, the EGFR or ALK mutation was not common for LC-ILD: low (646 doctors/63.7%) or hardly (306 doctors/30.5%) positive mutation. The diagnosis of ILD was earlier than LC (506 doctors/49.9%) or there was no identified precedence of LC and ILD diagnosis (208 doctors/20.5%). Most of the doctors (693 doctors/68.3%) agreed that the vital factor for surgery or not was the severity of ILD for LC-ILD patients. There were great divergences on the treatment protocol both for the advanced LC and ILD. The patients with LC-ILD were died mostly from LC progression and ILD exacerbation (542 doctors/53.5%), followed by ILD exacerbation (237 doctors/23.4%) or LC progression (226 doctors/22.3%). Conclusions: The elderly male patients were predisposed to LC-ILD, and adenocarcinoma was the common pathological pattern. The LC-ILD patients with non-advanced LC who were performed with surgery had better prognosis. However, it is recommended to consider whether to perform surgery in combination with the severity of the ILD. 目的: 总结肺癌并间质性肺疾病(LC-ILD)患者的临床特征、转归并调查LC-ILD诊疗相关科室医师对于本病的认知现况。 方法: 回顾性分析自2014年至2018年在我院住院接受诊疗、经病理确诊的肺癌患者中并发间质性肺疾病的70例LC-ILD患者的临床资料;通过电子问卷在全国29个省级行政区医院内调查LC-ILD诊疗相关科室医师对LC-ILD诊疗的认知现况。 结果: 70例LC-ILD患者中男性52例,年龄(49~84)岁,平均(64.3±7.63)岁,≥60岁共51例。腺癌是最常见的病理类型,绝大部分患者是肺癌和间质性肺疾病被同时诊断;化疗是最常用的内科治疗措施。EGFR或ALK的基因突变阳性11例/15.7%。45例/64.3%死亡,其中33例死于肺癌进展。外科手术组17例/24.3%,非外科手术组53例/75.7%:两组在年龄、肺癌的病理类型、驱动基因突变等方面无差异,但外科手术组的肺癌分期早、预后更好(P<0.001)。回收有效问卷1 014份:老年(785份/77.4%)、男性(720份/71%)是LC-ILD的好发人群,腺癌(390份/38.5%)、腺癌或鳞癌(182份/17.9%)、鳞癌(151份/14.9%)是常见的病理类型,大部分认为EGFR或ALK的突变低(646份/63.7%)或几乎无(309份/30.5%),ILD发生早于肺癌(506份/49.9%)或两者发生顺序无规律(208份/20.5%);大部分认为要视ILD病情程度来决定是否安排早期LC-ILD患者的外科手术(693份/68.3%),针对肺癌的非手术治疗及针对ILD的治疗措施上分歧很大,ILD和肺癌均进展(542份/53.5%)是主要死因,其次为ILD进展(237份/23.4%)、肺癌进展(226份/22.3%)。 结论: LC-ILD患者以老年、男性多见,腺癌是常见的病理类型;建议结合ILD的病情程度考量是否外科手术,早期肺癌患者手术切除后预后相对好。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu XN, Li J, Chen RX, et al. [Retrospective analysis and a cross-sectional questionnaire survey of lung cancer concomitant with interstitial lung disease]. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 36480849. doi:10.3760/cma.j.cn112147-20220815-00682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。